Structure Therapeutics to Participate in Upcoming Healthcare Investor Conferences
Structure Therapeutics will present at three New York healthcare investor conferences, with live and archived webcasts available on its investor relations site.
Rhea-AI Summary
Structure Therapeutics (GPCR) will participate in three healthcare investor conferences in September 2026, featuring fireside chats and 1x1 meetings.
Events include the Cantor Global Healthcare Conference on Thursday, September 10 (3:55–4:25 PM EDT), the Morgan Stanley 24th Annual Global Healthcare Conference on Wednesday, September 16 (10:45–11:20 AM EDT), and Bernstein’s 3rd Annual Healthcare Forum on Wednesday, September 23 (3:00–3:40 PM EDT), all in New York, NY. Live and archived webcasts will be available on the company’s investor relations website for at least 90 days.
Positive
- None.
Negative
- None.
Key Figures
Historical Context
| Date | Event | Sentiment | 24h Move | Catalyst |
|---|---|---|---|---|
| Aug 06 | Q2 earnings report | Positive | +1.0% | Reported Q2 results, Phase 3 dosing, and liquidity expected through 2028 |
| Jun 05 | Phase 2b clinical data | Positive | +0.5% | Reported statistically significant weight loss and planned Phase 3 initiation |
| May 26 | Investor conference participation | Neutral | -0.1% | Announced two June healthcare conferences with fireside chats and meetings |
| May 07 | Q1 earnings report | Positive | -0.1% | Reported Phase 2 data, FDA feedback, and planned Phase 3 initiation |
| Apr 27 | Conference presentation | Positive | -3.9% | Announced clinical and preclinical presentations at ADA scientific sessions |
24h Move is the share-price change in the day after each event; other market factors may also have contributed.
GPCR had positive reactions to the June 5 clinical-data and August 6 earnings announcements, but negative reactions to the May 7 earnings, May 26 conference, and April 27 presentation announcements.
AI-generated analysis. How Rhea-AI works. Not financial advice.
SAN FRANCISCO, Sept. 03, 2026 (GLOBE NEWSWIRE) -- Structure Therapeutics Inc. (NASDAQ: GPCR), a clinical-stage global biopharmaceutical company developing novel oral small molecule therapeutics for metabolic diseases, with a focus on obesity, today announced that management will participate in three upcoming healthcare conferences in September:
2026 Cantor Global Healthcare Conference
Date: Thursday, September 10
Format: Fireside chat and 1x1 meetings
Time: 3:55 – 4:25 PM EDT
Location: New York, NY
Morgan Stanley 24th Annual Global Healthcare Conference
Date: Wednesday, September 16
Format: Fireside chat and 1x1 meetings
Time: 10:45 – 11:20 AM EDT
Location: New York, NY
Bernstein’s 3rd Annual Healthcare Forum
Date: Wednesday, September 23
Format: Fireside Chat and 1x1 meetings
Time: 3:00 – 3:40 PM EDT
Location: New York, NY
The live and archived webcasts will be accessible from the company’s website at https://ir.structuretx.com/events-presentations/events and replays will be available for at least 90 days.
About Structure Therapeutics
Structure Therapeutics is a science-driven clinical-stage biopharmaceutical company focused on discovering and developing innovative oral small molecule treatments for chronic metabolic conditions with significant unmet medical needs. Utilizing its next generation structure-based drug discovery platform, the Company has established a robust GPCR-targeted pipeline, featuring multiple wholly-owned proprietary clinical-stage oral small molecule compounds designed to surpass the scalability limitations of traditional biologic and peptide therapies and be accessible to more people living with obesity around the world. For additional information, please visit www.structuretx.com.
Investors:
Corey Davis, Ph.D.
LifeSci Advisors, LLC
212-915-2577
cdavis@lifesciadvisors.com
Jennifer Robinson
Structure Therapeutics Inc.
jennifer.robinson@structuretx.com
Media:
Dan Budwick
1AB
Dan@1abmedia.com
